Ectopic lymphoid neogenesis in rheumatic autoimmune diseases

Michele Bombardieri,Myles Lewis,Costantino Pitzalis
DOI: https://doi.org/10.1038/nrrheum.2016.217
IF: 32.286
2017-02-09
Nature Reviews Rheumatology
Abstract:Key PointsEctopic lymphoid structures (ELSs) develop in the target organs of a subset of patients with rheumatic autoimmune diseases and recapitulate key cellular and molecular features normally present in secondary lymphoid organsELSs in rheumatic autoimmune diseases can function as germinal centres, favouring B cell selection and plasma cell differentiationB cells and plasma cells associated with ELSs in rheumatic autoimmune diseases frequently display an autoreactive phenotype towards disease-specific autoantigensEctopic germinal centres in patients with Sjögren syndrome have been associated with more severe systemic manifestations and a higher risk of B cell lymphomaIn rheumatoid arthritis, emerging but as-yet-inconclusive evidence suggests a role for ELSs in influencing disease evolution and the response to conventional and biologic treatmentsSeveral candidate therapeutic agents that target ELS-associated pathways are currently in clinical trials for rheumatic autoimmune diseases
rheumatology
What problem does this paper attempt to address?